Abstract:Objective The study is aimed to learn the influence of rapamycin on the sensitivity of cisplatin in ovarian cancer cell lines, and to investigate the relationship between the mTOR signaling pathway and cisplatin-resis-tance in ovarian cancer cell lines, besides, the molecular mechanism of the cytotoxic effects of rapamycin on ovarian cancer cell lines is preliminarily explored. Method The resistance index (RI) and cell proliferation inhibition rate were analyzed by CCK-8 assay. After the administration of different therapies, the influence of colony formation on the two cell lines were evaluated with clone tablet experiment. The different expression of proteins in both cell lines were detected using Western blot. Result 1) The RI of SKOV3/DDP cell line was 6.10, indicating a moderate resis-tance to cisplatin. 2) In SKOV3 cell line, the cell proliferation inhibition rate of combined therapy groups were signif-icantly higher than that of cisplatin groups after treatment for 24 h and 48 h (P<0.01), while there was no statistical difference after 72 h treatment (P>0.05). In SKOV3/DDP cell line, the cell proliferation inhibition rates of combined therapy groups were significantly higher compared to cisplatin groups in 24 h, 48 h, 72 h, with statistically significant difference (P<0.01). 3) In SKOV3 cell line, when cells were incubated with cisplatin + rapamycin for 4h, the colo-ny formation inhibition rate was significantly higher when compared with the cisplatin groups (P <0.01). 4)Gray-scale analysis showed that p-mTOR and p-AKT were overexpressed in SKOV3/DDP, while mTOR, AKT had similar ex-pression. 5) Rapamycin + cisplatin had more cleavage than cisplatin groups. 6) SKOV3 cell line had a decreased ex-pression of BCL2, and an increased transformation from LC3BI to LC3BII when treated with rapamycin for 24 hours; And those were not observed in SKOV3/DDP cell line. Conclusion 1) In vitro, rapamycin can enhance the chemosensitivity of SKOV3 and SKOV3/DDP cell lines to cisplatin. 2) The activation of the mTOR pathway may play an important role in the development of cisplatin-resistance. 3) Rapamycin increases the chemosensitivity of SKOV3 cell line to cisplatin, of which the underlying molecular mechanisms may include: enhancement of cisplatin-induced DNA cleavage, downregulation of BCL2 and induce of autophagy, while the mechanisms involved in SKOV3/DDP cell line only include the enhancement of cisplatin-induced DNA cleavage.

Regulation of survival and chemoresistance by HSP90AA1 in ovarian cancer SKOV3 cells

HSP60-regulated Mitochondrial Proteostasis and Protein Translation Promote Tumor Growth of Ovarian Cancer

ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer

The HSP70 gene predicts prognosis and response to chemotherapy in epithelial ovarian cancer

Circadian Clock Protein PERIOD2 Suppresses the PI3K/Akt Pathway and Promotes Cisplatin Sensitivity in Ovarian Cancer

Identification of Three Potential Prognostic Genes in Platinum-Resistant Ovarian Cancer Via Integrated Bioinformatics Analysis.

Overexpression of SMARCA2 or CAMK2D is Associated with Cisplatin Resistance in Human Epithelial Ovarian Cancer

Clinicopathological and biological significance of aberrant activation of glycogen synthase kinase-3 in ovarian cancer.

53BP1 Inhibits the Migration and Regulates the Chemotherapy Resistance of Ovarian Cancer Cells.

HSP90AB1 As the Druggable Target of Maggot Extract Reverses Cisplatin Resistance in Ovarian Cancer.

Effect of Sirna-Induced Atg7 Gene Silencing on the Sensitivity of Ovarian Cancer SKOV3 Cells to Cisplatin.

PGC1α Promotes Cisplatin Resistance in Ovarian Cancer by Regulating the HSP70/HK2/VDAC1 Signaling Pathway

Astragalus polysaccharides increase the sensitivity of SKOV3 cells to cisplatin

Silencing HDAC1 Expression Regulates Extracellular Regulated Protein Kinases/Mitogen-Activated Protein Kinase Signaling Activation and Enhances Chemosensitivity of Ovarian Carcinoma

[Experimental Study on Resistance to Cisplatin and Taxol in Human Ovarian Cancer SKOV3ip1 Multicellular Aggregates].

Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving

Mechanism of rapamycin increasing the chemosensitivity of ovarian cancer cell lines to cisplatin

Exosomal miR‐21‐5p derived from cisplatin‐resistant SKOV3 ovarian cancer cells promotes glycolysis and inhibits chemosensitivity of its progenitor SKOV3 cells by targeting PDHA1

SHCBP1 promotes cisplatin resistance of ovarian cancer through AKT/mTOR/Autophagy pathway

Mitochondrial Dynamics Mediated by DRP1 and MFN2 Contributes to Cisplatin Chemoresistance in Human Ovarian Cancer SKOV3 cells

miR-874-3p mitigates cisplatin resistance through modulating NF-κB/inhibitor of apoptosis protein signaling pathway in epithelial ovarian cancer cells